Forecast & Rating2 analysts currently cover AN2 Therapeutics, of which 2 give a positive rating. The average price target is $9.00, about 66.4% upside from the current price of $5.41. Coverage is limited, so the data is for reference only. Data as of Aug 14, 2026; this does not constitute investment advice.
Aug 14, 2026Price forecast
$9.0066.36%
Forecast & RatingStrong buy
2analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateSep 7, 2026
Forecast met27.5%
Stock price$5.41
Avg. target$1.0
High target$1
Low target$1
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.